A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 16, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

July 31, 2029

Conditions
ObesityOverweight
Interventions
DRUG

Tirzepatide

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (33)

21229

Barry J. Reiner, MD, LLC, Baltimore

28100

Azienda Ospedaliero Universitaria Maggiore della Carità, Novara

30030

CenExel iResearch, LLC, Decatur

37126

Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento, Verona

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna

43213

Aventiv Research Inc, Columbus

45429

PriMED Clinical Research, Dayton

55414

M Health Fairview - Delaware Clinical Research Unit (DCRU), Minneapolis

58633

Nemocnice Jihlava, Jihlava

63110

Washington University School of Medicine, St Louis

66606

Cotton O'Neil Diabetes & Endocrinology, Topeka

70300

Yitzhak Shamir Medical Center, Beer Yaacov

70808

Pennington Biomedical Research Center, Baton Rouge

83646

Solaris Clinical Research, Meridian

98125

Azienda Ospedaliera Universitaria Di Messina G. Martino, Messina

372212

Vanderbilt Health One Hundred Oaks, Nashville

1834111

Emek Medical Center, Afula

3109601

Rambam Health Care Campus, Haifa

4920235

Schneider Children's Medical Center, Petah Tikva

5262100

Sheba Medical Center, Ramat Gan

8410101

Soroka Medical Center, Beersheba

9013102

Shaare Zedek Medical Center, Jerusalem

T6G 2E1

Alberta Diabetes Institute, Edmonton

L8L 5G8

The Wharton Medical Clinic Clinical Trials Inc, Hamilton

M5G 1X8

The Hospital for Sick Children, Toronto

G7H 5H6

CIUSSS- saguenay-Lac-Saint-Jean, Chicoutimi

779 00

ReFit Clinic, Olomouc

703 84

Nemocnice AGEL Ostrava - Vitkovice a.s., Ostrava

150 06

Fakultni nemocnice v Motole, Prague

100 34

Fakultni nemocnice Kralovske Vinohrady, Prague

02-117

Instytut Diabetologii, Warsaw

41-800

Samodzielny Publiczny Szpital Kliniczny nr 1 SUM, Zabrze

91-738

Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi, Uniwersyteckie Centrum Pediatrii im. M. Konop -T, Lodz

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT06075667 - A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities | Biotech Hunter | Biotech Hunter